Date published: 2025-11-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pirenzepine-d8 Dihydrochloride

0.0(0)
Write a reviewAsk a question

Application:
Pirenzepine-d8 is a deuterium-labeled analogue of Pirenzepine
Molecular Weight:
432.37
Molecular Formula:
C19H13D8N5O22HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Pirenzepine-d8 is a deuterium-labeled analogue of Pirenzepine. Pirenzepine (sc-204197) is a selective antagonist for the M1 muscarinic receptor (mAChR) and is reported to block presynaptic M1 receptors as well as some reported inverse agonist activity. A study investigating the pharmacological characterization of the muscarinic receptors associated with ACh-induced pulmonary vasodilation in a rabbit model of pulmonary hypertension determined the IC50 to be 2.51x10-7M. Additional research studies have investigated the role of Pirenzepine in the pathophysiology of myopia. Other M1 receptor antagonists offered include Telenzepine (sc-204332).


Pirenzepine-d8 Dihydrochloride References

  1. Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors.  |  Daeffler, L., et al. 1999. Br J Pharmacol. 126: 1246-52. PMID: 10205015
  2. M₃muscarinic receptors mediate acetylcholine-induced pulmonary vasodilation in pulmonary hypertension.  |  Orii, R., et al. 2010. Biosci Trends. 4: 260-6. PMID: 21068480
  3. Presynaptic muscarinic receptor subtypes involved in the enhancement of spontaneous GABAergic postsynaptic currents in hippocampal neurons.  |  González, JC., et al. 2011. Eur J Neurosci. 33: 69-81. PMID: 21091801
  4. The interaction between tropomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals.  |  Garcia, N., et al. 2010. J Neurosci. 30: 16514-22. PMID: 21147991

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Pirenzepine-d8 Dihydrochloride, 1 mg

sc-219626
1 mg
$380.00